Core Laboratories Inc. (CLB) To Go Ex-Dividend on August 10th

Core Laboratories Inc. (NYSE:CLB) declared a quarterly dividend on Wednesday, July 29th. Investors of record on Monday, August 10th will be given a dividend of 0.01 per share by the oil and gas company on Monday, August 31st. This represents a c) annualized dividend and a yield of 0.4%. The ex-dividend date is Monday, August 10th.

Core Laboratories has decreased its dividend by an average of 0.3%per year over the last three years. Core Laboratories has a dividend payout ratio of 4.7% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Core Laboratories to earn $0.79 per share next year, which means the company should continue to be able to cover its $0.04 annual dividend with an expected future payout ratio of 5.1%.

Core Laboratories Stock Performance

Shares of Core Laboratories stock opened at $11.33 on Friday. The stock has a market capitalization of $519.68 million, a price-to-earnings ratio of 20.23, a price-to-earnings-growth ratio of 2.70 and a beta of 1.03. The company has a debt-to-equity ratio of 0.41, a current ratio of 2.12 and a quick ratio of 1.55. The business has a 50-day moving average of $11.71 and a 200 day moving average of $14.94. Core Laboratories has a 12 month low of $9.72 and a 12 month high of $20.36.

Core Laboratories (NYSE:CLB) last issued its quarterly earnings results on Wednesday, July 29th. The oil and gas company reported $0.11 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.09 by $0.02. The company had revenue of $124.61 million for the quarter, compared to analyst estimates of $126.26 million. Core Laboratories had a net margin of 5.10% and a return on equity of 10.03%. The business’s revenue for the quarter was down 4.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.19 earnings per share. Core Laboratories has set its Q3 2026 guidance at 0.120-0.200 EPS. As a group, sell-side analysts forecast that Core Laboratories will post 0.53 earnings per share for the current year.

Insiders Place Their Bets

In related news, CEO Lawrence Bruno purchased 5,000 shares of the business’s stock in a transaction on Friday, July 31st. The shares were bought at an average price of $10.78 per share, for a total transaction of $53,900.00. Following the acquisition, the chief executive officer directly owned 262,438 shares in the company, valued at $2,829,081.64. This trade represents a 1.94% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 1.26% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Core Laboratories

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. BlackRock Inc. acquired a new stake in shares of Core Laboratories in the 2nd quarter valued at $86,910,000. Goldman Sachs Group Inc. grew its stake in shares of Core Laboratories by 185.0% during the fourth quarter. Goldman Sachs Group Inc. now owns 845,251 shares of the oil and gas company’s stock worth $13,549,000 after purchasing an additional 548,657 shares in the last quarter. Disciplined Growth Investors Inc. MN grew its stake in shares of Core Laboratories by 9.7% during the third quarter. Disciplined Growth Investors Inc. MN now owns 5,969,860 shares of the oil and gas company’s stock worth $73,787,000 after purchasing an additional 528,976 shares in the last quarter. Bank of New York Mellon Corp purchased a new position in Core Laboratories in the second quarter valued at $4,675,000. Finally, MAC Alpha Capital Management LP purchased a new position in Core Laboratories in the fourth quarter valued at $5,016,000. 97.81% of the stock is owned by institutional investors and hedge funds.

About Core Laboratories

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.